Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Etsuo Kimori"'
Autor:
Yasunobu Uchida, Minoru Uchida, Etsuo Kimori, Atsushi Nakamura, Ken-ichi Michi, Nobuo Takano, Yoshio Iwasaki, Noboru Sonoyama, Chikara Saito, Yohko Ikawa, Hisao Hoshiyama, Yasuo Kumazawa, Haruyasu Tanabe, Katsunori Ishibashi, Shojiro Takahashi, Reiji Suzuki
Publikováno v:
Japanese Journal of Oral & Maxillofacial Surgery. 36:2387-2402
Optimal dose of N-22 (Mofezolac), a new non-steroidal anti-inflammatory agent, was evaluated in a double-blind comparative study on post-exodontic pain, at 3 single dosing levels of 100 mg, 150 mg and 200 mg, respectively. The results are summarized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f60af7d2ccc477eca364f4b9dca695d2
https://doi.org/10.5794/jjoms.36.2387
https://doi.org/10.5794/jjoms.36.2387
Autor:
Atsushi Nakamura, Katsunori Ishibashi, Nobuo Takano, Masahiro Nakazawa, Yasuo Kumazawa, Shojiro Takahashi, Chikara Saito, Noboru Sonoyama, Minoru Uchida, Yoshio Iwasaki, Yasukazu Kudo, Yasunobu Uchida, Ken-ichi Michi, Haruyasu Tanabe, Etsuo Kimori, Hidekuni Ozeki
Publikováno v:
Japanese Journal of Oral & Maxillofacial Surgery. 36:2403-2414
Clinical usefulness of N-22 (Mofezolac; N), a new non-steroidal antiinflammatory agent, on post-exodontic pain was evaluated at a single dose level of 150mg/time, in a double-blind comparative study, in comparison with Mefenamic acid; M also at a sin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e7ef897394392f00160ce34a33a8859
https://doi.org/10.5794/jjoms.36.2403
https://doi.org/10.5794/jjoms.36.2403